FASN and cancer: FASN coding for fatty acid synthase, which catalyzes the formation of long-chain fatty acids from acetyl-CoA, malonyl-CoA, and NADPH, plays an important role in the growth and survival of cancers with lipogenic characteristics [7] and has been suggested as a potential therapeutic target for the early stages of CRC [8].